Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05338346
Title A Study of ATG-018 (ATR Inhibitor) Treatment in Patients With Advanced Solid Tumors and Hematological Malignancies (ATRIUM)
Acronym ATRIUM
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Antengene Discovery Limited
Age Groups: senior | adult
Covered Countries AUS

Additional content available in CKB BOOST